每年專案
個人檔案
學歷
- 1992 臺北醫學大學藥學博士
- 1985 臺北醫學大學藥學碩士
- 1983 臺北醫學大學藥學學士
經歷
- 2012 臺北醫學大學藥物科學學科教授
- 2003-2012 臺北醫學大學藥學系教授
研究興趣
- 藥物分析
- 藥物傳遞系統
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
專案
- 12 已完成
-
開發熱安定性醣化PLGA奈米顆粒負載以SARS-CoV-2 spike protein編碼的mRNA作為新型冠狀病毒疫苗之研究
Ho, H.-O. (PI)
8/1/22 → 7/31/23
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
發展可標靶樹突細胞之mPEG-PLGA/PLGA-PEG-PLGA混和水膠體的奈米顆粒癌症疫苗用於癌症免疫療法(3/3)
Ho, H.-O. (PI)
8/1/21 → 7/31/22
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
發展可標靶樹突細胞之mPEG-PLGA/PLGA-PEG-PLGA混和水膠體的奈米顆粒癌症疫苗用於癌症免疫療法(2/3)
Ho, H.-O. (PI)
8/1/20 → 7/1/21
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
發展可標靶樹突細胞之mPEG-PLGA/PLGA-PEG-PLGA混和水膠體的奈米顆粒癌症疫苗用於癌症免疫療法(1/3)
Ho, H.-O. (PI)
8/1/19 → 7/31/20
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
開發可遞送粒細胞-巨噬細胞集落刺激因子(GM-CSF)的注射型溫感性水膠載體於癌症免疫療法之應用
Ho, H.-O. (PI)
8/1/18 → 7/1/19
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
Bioactive matrix scaffold of oxidized sacchachitin via green catalyst of siliacat tempo for enhancing bone regeneration
Sheu, M. T., Lin, S. Y., Cheng, W. J., Lin, H. L., Hsieh, C. M., Ho, H. O., Chen, L. C. & Wu, M. H., 12月 2024, 於: Carbohydrate Polymer Technologies and Applications. 8, 100576.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids
Chou, P. Y., Lai, M. J., Tsai, K. K., Cheng, L. H., Wu, Y. W., Chen, M. C., Pan, S. L., Ho, H. O., Nepali, K. & Liou, J. P., 2024, (接受/付印) 於: Journal of Medicinal Chemistry. 67, 19, p. 17207-17225 19 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯(Scopus) -
Composite Hydrogels of Ultrasound-Assisted-Digested Formic Acid-Decellularized Extracellular Matrix and Sacchachitin Nanofibers Incorporated with Platelet-Rich Plasma for Diabetic Wound Treatment
Lin, C. J., Lin, H. L., You, W. C., Ho, H. O., Sheu, M. T., Chen, L. C. & Cheng, W. J., 8月 2023, 於: Journal of Functional Biomaterials. 14, 8, 423.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 引文 斯高帕斯(Scopus) -
Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer
Liu, Y. H., Chen, L. C., Cheng, W. T., Wei, P. S., Hsieh, C. M., Sheu, M. T., Lin, S. Y., Ho, H. O. & Lin, H. L., 2月 2023, 於: Pharmaceutics. 15, 2, 473.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯(Scopus) -
Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy
Cheng, W. J., Chuang, K. H., Lo, Y. J., Chen, M., Chen, Y. J., Roffler, S. R., Ho, H. O., Lin, S. Y. & Sheu, M. T., 1月 2022, 於: Journal of Controlled Release. 344, p. 235-248 14 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
13 引文 斯高帕斯(Scopus)
資料集
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Hsieh, C.-M. (Contributor), Chen, L.-C. (Contributor), Liu, D.-Z. (Contributor), Ho, H.-O. (Contributor), Su, C.-Y. (Contributor), Sheu, M.-T. (Contributor), Jhan, H.-J. (Contributor) & Chang, C.-E. (Contributor), Unknown Publisher, 2018
DOI: 10.6084/m9.figshare.5908795, https://doi.org/10.6084%2Fm9.figshare.5908795
資料集: Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C.-Y. (Contributor), Chen, M. (Contributor), Chen, L.-C. (Contributor), Ho, Y.-S. (Contributor), Ho, H.-O. (Contributor), Lin, S.-Y. (Contributor), Chuang, K.-H. (Contributor) & Sheu, M.-T. (Contributor), Unknown Publisher, 5月 2 2018
DOI: 10.6084/m9.figshare.6213620.v1, https://tandf.figshare.com/articles/Bispecific_antibodies_anti-mPEG_anti-HER2_for_active_tumor_targeting_of_docetaxel_DTX_-loaded_mPEGylated_nanocarriers_to_enhance_the_chemotherapeutic_efficacy_of_HER2-overexpressing_tumors/6213620/1
資料集: Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Chen, L.-C. (Contributor), Lin, S.-Y. (Contributor), Sheu, M.-T. (Contributor), Ho, Y.-S. (Contributor), Su, C.-Y. (Contributor), Chen, M. (Contributor), Ho, H.-O. (Contributor) & Chuang, K.-H. (Contributor), Unknown Publisher, 2018
DOI: 10.6084/m9.figshare.6213620, https://doi.org/10.6084%2Fm9.figshare.6213620
資料集: Dataset
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Chang, C.-E. (Contributor), Hsieh, C.-M. (Contributor), Chen, L.-C. (Contributor), Su, C.-Y. (Contributor), Liu, D.-Z. (Contributor), Jhan, H.-J. (Contributor), Ho, H.-O. (Contributor) & Sheu, M.-T. (Contributor), Unknown Publisher, 1月 1 2018
DOI: 10.6084/m9.figshare.5908795.v1, https://tandf.figshare.com/articles/Novel_application_of_pluronic_lecithin_organogels_PLOs_for_local_delivery_of_synergistic_combination_of_docetaxel_and_cisplatin_to_improve_therapeutic_efficacy_against_ovarian_cancer/5908795/1
資料集: Dataset